Vitamin D receptor gene BsmI and TaqI polymorphisms and fracture risk: a meta-analysis

Bone. 2006 Oct;39(4):938-45. doi: 10.1016/j.bone.2006.04.016.

Abstract

Introduction: Fracture is the major clinical outcome of osteoporosis. The vitamin D receptor (VDR) gene is thought to be a candidate gene for osteoporosis. Many genetic studies have suggested an association of VDR polymorphisms and osteoporosis, but evidence remains conflicting.

Materials and methods: We searched published studies from 1996 to September 2005 through PubMed and evaluated the genetic effect of the BsmI and TaqI polymorphism of VDR on fracture risk in a meta-analysis. Thirteen studies with a total of 20 eligible comparisons (1632 fracture cases and 5203 controls) were analyzed with fixed and random effects models.

Result: No evidence of relationship between the VDR BsmI or TaqI polymorphism and fracture risk was observed with any genetic model. The odds ratio (95% confidence interval) of b-allele versus B-allele was 0.98 (0.86-1.12) with random effects calculations. There was significant between-study heterogeneity. Small studies did not differ significantly from larger ones.

Conclusion: No relationship of the VDR BsmI or TaqI polymorphism and fracture risk was found in the meta-analysis of published data.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Deoxyribonucleases, Type II Site-Specific / metabolism
  • Female
  • Fractures, Bone / genetics*
  • Gene Frequency
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Male
  • Middle Aged
  • Odds Ratio
  • Osteoporosis / genetics
  • Polymorphism, Restriction Fragment Length*
  • Receptors, Calcitriol / genetics*

Substances

  • Receptors, Calcitriol
  • endodeoxyribonuclease BsmI
  • Deoxyribonucleases, Type II Site-Specific
  • TCGA-specific type II deoxyribonucleases